Vijaypd Ceutical
VIJAYPD NSE
Vijaypd Ceutical
IndustrialsNSE: VIJAYPD Electrical Equipment
Key Fundamentals
SMEPharmacy RetailRetailMarket Cap
₹121 Cr
Volatility
Moderate
P/E Ratio
24.2
EBITDA
₹4.71 Cr
Return on Equity
14.91%
Debt to Equity
0.64
Book Value
₹26.88
52W High
₹114.5
52W Low
₹35
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
5- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.4.02 Cr.
- Debtor days have increased from 85.8 to 115 days.
- Working capital days have increased from 21.1 days to 64.7 days
Growth Rate
Revenue Growth
-16.06% lower than
3Y
Net Income Growth
-1.46% lower than
3Y
ROE
-40.46% lower than
3Y
ROCE
-55.57% lower than
3Y
EBITDA Margin (Avg.)
-42.52% higher than
3Y
Quarterly Results
| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 50.32 | 49.91 | 51.33 | 47.62 |
| Expenses | 44.84 | 46.99 | 46.97 | 47.27 |
| Operating Profit | 5.48 | 2.92 | 4.36 | 0.35 |
| OPM % | 10.89% | 5.85% | 8.49% | 0.73% |
| Other Income | 0.01 | 0.75 | 0.32 | 3.7 |
| Interest | 1.17 | 0.98 | 1.06 | 0.53 |
| Depreciation | 0.3 | 0.31 | 0.28 | 0.34 |
| PBT | 4.02 | 2.38 | 3.34 | 3.18 |
| Tax % | 26.62% | 26.05% | 27.84% | 16.67% |
| Net Profit | 2.95 | 1.76 | 2.42 | 2.64 |
| EPS in Rs | 4.21 | 1.25 | 1.73 | 1.35 |
Profit & Loss
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 51.09 | 59.15 | 117 | 98.96 |
| Expenses | 49.77 | 54.27 | 109 | 94.25 |
| Operating Profit | 1.32 | 4.88 | 8.58 | 4.71 |
| OPM % | 2.58% | 8.25% | 7.33% | 4.76% |
| Other Income | 1.82 | 0 | 0.78 | 4.02 |
| Interest | 2.36 | 1.76 | 2.15 | 1.59 |
| Depreciation | 0.43 | 0.35 | 0.69 | 0.62 |
| PBT | 0.35 | 2.77 | 6.52 | 6.52 |
| Tax % | 48.57% | 40.43% | 26.53% | 22.39% |
| Net Profit | 0.18 | 1.65 | 4.8 | 5.06 |
| EPS in Rs | — | — | 3.42 | 2.59 |
| Div. Payout % | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 0 | 1 | 14.03 | 19.53 |
| Reserves | 4.93 | 5.59 | 18.14 | 33.01 |
| Borrowings | 25.57 | 24.45 | 21.77 | 33.67 |
| Other Liabilities | 2.37 | 2.23 | 3.21 | 11.15 |
| Total Liabilities | 32.87 | 33.27 | 57.15 | 97.36 |
| Fixed Assets | 2.73 | 2.43 | 8.44 | 8.72 |
| CWIP | 0 | 0 | 0.11 | 1.66 |
| Investments | 0.16 | 0.15 | 0.25 | 2.09 |
| Other Assets | 29.98 | 30.69 | 48.35 | 84.89 |
| Total Assets | 32.87 | 33.27 | 57.15 | 97.36 |
Cash Flow
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating | 0.3 | 2.93 | -7.89 | -7.32 |
| Investing | -0.09 | 12.78 | -0.55 | -12.17 |
| Financing | -0.18 | -1.86 | -2.38 | 25.37 |
| Net Cash Flow | 0.03 | 13.84 | -10.82 | 5.88 |
| Free Cash Flow | 0.28 | 2.87 | -8.64 | -9.46 |
| CFO/OP | 38 | 60 | -80 | -128 |
Ratios
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor Days | 62.44 | 68.56 | 74.19 | 115 |
| Inventory Days | 30.97 | 28.85 | 42.6 | 46.48 |
| Days Payable | 15.44 | 5.13 | 7.71 | 31.77 |
| Cash Conversion Cycle | 77.96 | 92.29 | 109 | 129 |
| Working Capital Days | -83.94 | -60.1 | 58.73 | 64.69 |
| ROCE % | — | 14.75% | 20.4% | 11.59% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Vijaypd Ceutical insights
29 extracted metrics + investor summaries across FY23–FY26.
Documents
1
Copy of Newspaper Publication
6 Sep - AGM notice published; 42nd AGM on 28 September 2026, e-voting 25-27 September, book closure 23-29 September. 6 Sep - AGM notice published; 42nd AGM on 28 September 2026, e-voting 25-27 September, book closure 23-29 September.
2
Shareholders meeting
4 Sep - 2nd AGM on 30 Sep 2026; annual report filed, with related-party, loan and remuneration approvals proposed. 4 Sep - 2nd AGM on 30 Sep 2026; annual report filed, with related-party, loan and remuneration approvals proposed.
3
Outcome of Board Meeting
29 Aug - Board approved 2nd AGM notice, FY26 directors' report, cut-off date, and secretarial auditor appointment. 29 Aug - Board approved 2nd AGM notice, FY26 directors' report, cut-off date, and secretarial auditor appointment.
4
Updates
26 Aug - Received EOI from Squadron Pharmaceuticals LLP for API contract manufacturing of Sitagliptin, Apixaban and Rivaroxaban. 26 Aug - Received EOI from Squadron Pharmaceuticals LLP for API contract manufacturing of Sitagliptin, Apixaban and Rivaroxaban.
5
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
3 Jul - Vijaypd Ceutical says corporate governance report not required for quarter ended 30 June 2026 under NSE EMERGE exemption. 3 Jul - Vijaypd Ceutical says corporate governance report not required for quarter ended 30 June 2026 under NSE EMERGE exemption.
Frequently Asked Questions about Vijaypd Ceutical
What does Vijaypd Ceutical Ltd do?
Incorporated in October 1971, Vijaypd Ceutical Limited distributes pharmaceutical products and consumer goods, offering a comprehensive range of services.[1]
Where is Vijaypd Ceutical Ltd (VIJAYPD) listed?
Vijaypd Ceutical Ltd trades as VIJAYPD on the NSE.
Which sector does Vijaypd Ceutical Ltd belong to?
Vijaypd Ceutical Ltd is classified under the Industrials sector, in the Electrical Equipment industry.
What is the market capitalisation of Vijaypd Ceutical Ltd?
Vijaypd Ceutical Ltd has a market capitalisation of ₹121.08 Cr, which places it in the Small Cap band.
What is the PE ratio of Vijaypd Ceutical Ltd?
Vijaypd Ceutical Ltd trades at a PE ratio of 24.20, against a book value of ₹26.88 per share.
What is the 52-week high and low of Vijaypd Ceutical Ltd?
Over the last 52 weeks Vijaypd Ceutical Ltd has traded between ₹35 and ₹114.5.
What is the Return on Equity (ROE) of Vijaypd Ceutical Ltd?
Vijaypd Ceutical Ltd reported a return on equity of 14.91%. Its debt-to-equity ratio is 0.64.
Company Information
Incorporated in October 1971, Vijaypd Ceutical Limited distributes pharmaceutical products and consumer goods, offering a comprehensive range of services.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/VIJAYPD.md for Vijaypd Ceutical Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.